Maryland Woman Found Guilty Of Leading Oxycodone Operation
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Maryland Woman Found Guilty Of Leading Oxycodone Operation

Maryland Woman Found Guilty Of Leading Oxycodone Operation

Junio 13, 2016
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Public Information Office
Phone Number: (571) 362-1934

(ALEXANDRIA, Va. - Roxanne Granberry, 35, of Hughesville, Maryland, was convicted today by a federal jury on charges of conspiracy to distribute oxycodone and obtaining oxycodone by fraud.

Granberry was indicted on February 3, 2016. According to court records and evidence presented at trial, Granberry and her husband, William Granberry, ran a large-scale drug conspiracy in which they created fraudulent prescriptions for narcotics and used drug runners in multiple pharmacies in Virginia and several other states to obtain thousands of oxycodone tablets. Both Granberrys’ recruited individuals to drive to pharmacies and fill the prescriptions. They also engaged in the direct sale and distribution of the oxycodone to numerous buyers in Virginia and other states. Since 2008, the criminal organization has fraudulently obtained approximately 130,000 oxycodone pills.  Thirteen other members of this conspiracy have also been convicted.

Granberry faces a maximum penalty of 20 years in prison when sentenced on September 16, 2016.  The maximum statutory sentence is prescribed by Congress and is provided here for informational purposes, as the sentencing of the defendant will be determined by the court based on the advisory Sentencing Guidelines and other statutory factors.

Karl C. Colder, Special Agent in Charge of the Drug Enforcement Administration’(DEA) Washington Field Division, Dana J. Boente, U.S. Attorney for the Eastern District of Virginia; and Paul M. Abbate, Assistant Director in Charge of the FBI’s Washington Field Office, made the announcement after the verdict was accepted by U.S. District Judge Anthony J. Trenga.  Special Assistant U.S. Attorneys Paul A. Hayden and Anna G. Kaminska, as well as Assistant U.S. Attorney Gene Rossi are prosecuting the case.

Boente also thanked the Department of Defense-Office of the Inspector General, Loudoun County Sheriff’s Office, Charles County Sheriff’s Office, Calvert County Sheriff’s Office, Washington, D.C. Metropolitan Police Department, Virginia State Police, and the Pennsylvania Attorney General’s Office for their assistance in this matter.

This case is part of the Organized Crime Drug Enforcement Task (OCDETF) Operation “Circuit Breaker,” which focused on the vast, illegal procurement and sale of prescription pain medication across the mid-Atlantic region and elsewhere, including Virginia, Maryland, Pennsylvania, Ohio, North Carolina, Georgia, Connecticut, Alabama, Tennessee, West Virginia, and Washington, D.C.  The OCDETF program is a federal multi-agency, multi-jurisdictional task force that supplies supplemental federal funding to federal and state agencies involved in the identification, investigation, and prosecution of major drug trafficking organizations. The principal mission of the OCDETF program is to identify, disrupt and dismantle the most serious drug trafficking, weapons trafficking and money laundering organizations, and those primarily responsible for the nation’s illegal drug supply.
Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Christopher C. Goumenis Special Agent in Charge - Washington, DC
@DEAWashingtonDC
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster